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Adverse life events during pregnancy may impact upon the developing fetus, predisposing
prenatally stressed offspring to the development of psychopathology. In the present study, we
examined the effects of prenatal restraint stress (PS) on anxiety- and depression-related
behavior in both male and female adult Sprague-Dawley rats. In addition, gene expression
proﬁles within the hippocampus and frontal cortex (FC) were examined in order to gain more
insight into the molecular mechanisms that mediate the behavioral effects of PS exposure.
PS signiﬁcantly increased anxiety-related behavior in male, but not female offspring. Likewise,
depression-related behavior was increased in male PS rats only. Further, male PS offspring
showed increased basal plasma corticosterone levels in adulthood, whereas both PS males andElsevier B.V. and ECNP. All rights reserved.
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1227Vulnerability versus resilience to PS in male and female ratsfemales had lower stress-induced corticosterone levels when compared to controls. Microarray-
based proﬁling of the hippocampus and FC showed distinct sex-dependent changes in gene
expression after PS. Biological processes and/or signal transduction cascades affected by PS
included glutamatergic and GABAergic neurotransmission, mitogen-activated protein kinase
(MAPK) signaling, neurotrophic factor signaling, phosphodiesterase (PDE)/ cyclic nucleotide
signaling, glycogen synthase kinase 3 (GSK3) signaling, and insulin signaling. Further, the data
indicated that epigenetic regulation is affected differentially in male and female PS offspring.
These sex-speciﬁc alterations may, at least in part, explain the behavioral differences observed
between both sexes, i.e. relative vulnerability versus resilience to PS in male versus female
rats, respectively. These data reveal novel potential targets for antidepressant and mood
stabilizing drug treatments including PDE inhibitors and histone deacetylase (HDAC) inhibitors.
& 2012 Elsevier B.V. and ECNP. All rights reserved.1. Introduction
Environmental adversity, either physical or emotional,
experienced by the mother during pregnancy, may impact
upon the developing fetus, adversely affecting its physical
and mental wellbeing in later life. In humans, prenatal
stress (PS) has been associated with the development of
various cognitive and affective disorders, such as depression
and anxiety (Huizink et al., 2004; Van den Bergh et al.,
2005; Weinstock, 2001). Likewise, PS in rats has been
associated with altered stress responsivity and increased
anxiety- and depression-related behavior, see review by
Huizink et al. (2004). These behavioral effects of PS can be
counteracted by treating prenatally stressed rat offspring
with various kinds of antidepressants (Alonso et al., 1999;
Morley-Fletcher et al., 2003a, 2004; Poltyrev et al., 2005;
Poltyrev and Weinstock, 2004). Therefore, PS in rats is
regarded as a valid ‘etiological’ animal model to obtain
more insight into the pathophysiology of affective disorders.
Similar to the human situation, the effects of PS exposure
in rats are highly sex-dependent. More speciﬁcally, PS in
Sprague-Dawley rats has been shown to particularly affect
male offspring, whereas females are relatively resilient at
the behavioral level (Zuena et al., 2008). Along similar
lines, e.g. the hippocampus – a brain structure that is
subject to sex-dependent development and is well-known
for its role in affective regulation – has been shown to be
differentially affected by PS in male and female rat off-
spring, which is indicative of sex-speciﬁc vulnerability to
disturbed glutamatergic and GABAergic neurotransmission
and reduced hippocampal neuroplasticity (e.g. Zuena et al.,
2008; Morley-Fletcher et al., 2011; Laloux et al., 2012).
In the present study, we examined the effects of PS in
both male and female Sprague-Dawley rats. Adult anxiety-
and depression-related behavior was studied using the
elevated zero maze test, the home cage emergence test,
the forced swim test, and the sucrose intake test. Further,
basal and stress-induced activity of the hypothalamus–
pituitary–adrenal (HPA) axis was studied. Finally, we exam-
ined the effects of PS on gene expression proﬁles within the
hippocampus and frontal cortex (FC), two brain regions
known to be critically involved in the pathophysiology of
depressive disorders and the response to antidepressant
treatment (Sheline et al., 2003; Taylor et al., 2008). For this
purpose, as a hypothesis-generating approach, a whole
genome microarray-based design was used in order toidentify the genes and related molecular pathways that
mediate vulnerability versus resilience to the behavioral
effects of developmental stress exposure in male and
female PS offspring, respectively.
2. Experimental procedures
2.1. Animals and procedures
This study was approved by the Animal Ethics Board of the
Maastricht University, The Netherlands. Acclimatized Sprague-
Dawley rats (Charles River, The Netherlands) were used. The
animals were housed individually within a temperature-controlled
environment (2171 1C) with a 12 h light/12 h dark cycle (lights on
from 7.00–19.00 h) and had access to standard rat chow and water
ad libitum. Pregnancy was determined by observation of vaginal
plugs (embryonic day 0–E0). Restraint stress was performed daily
during the last week of pregnancy (E14–E21). Pregnant female rats
(n=8) were individually restrained 3 times a day (at approximately
9.00, 13.00, and 17.00 h) for 45 min in transparent plastic cylinders,
whilst being exposed to bright light (Van den Hove et al., 2005;
Ward and Weisz, 1984). Control (C) pregnant females (n=8) were
left undisturbed in their home cages. Only litters of 8 or more pups
were included in this study. Litters were culled to 8 pups if
necessary. A maximum of 2 male and female pups per litter were
examined to prevent litter effects (Chapman and Stern, 1978).
At postnatal day 21 (P21), pups were weaned and group-housed
for further examination (2 male or 2 female rats/cage; n=14 rats
per experimental condition per sex). Rats were kept at a reversed
day–night cycle from this point onwards (lights on from 17.00–
5.00 h). Anxiety- and depression-related behavior of the rats was
analyzed from P120 onwards (in the order as discussed below).
Subsequently, at P143, plasma corticosterone secretion was
assessed. One week later, at P150, the animals were killed by quick
decapitation, after which the brains were removed. The hippocam-
pus and FC were dissected, weighed and bilateral tissue samples
were placed in a single tube and snapshot frozen in liquid nitrogen
after which they were stored at 80 1C until further analysis.
2.2. Anxiety- and depression-related behavior
The elevated zero maze (EZM) introduced by Shepherd et al. (1994)
consisted of a circular alley (diameter of 100 cm; path width 10 cm)
made from black plastic material that was transparent for infrared
light and elevated 20 cm above the ﬂoor. The maze was divided into
four parts, i.e., two opposite open parts and two opposite closed
parts with sidewalls 30 cm in height. The open parts had borders
with a height of 5 mm to prevent the rat from stepping down from
the apparatus. For the test, the rat was placed into one of the open
D.L.A. Van den Hove et al.1228parts facing a closed part of the apparatus. After 5 min the rat was
removed from the apparatus and the maze was cleaned with
ethanol (70%) and water and dried thoroughly. The movements of
the rat were scored automatically under dark conditions with a
computerized system using an infrared video camera (Ethovision
Pro, Noldus, The Netherlands). Percentage of time spent in the
open part of the maze and total distance traveled were
determined.
In the home cage emergence (HCE) test the rat’s home cage
(opened) was placed in the center of an open ﬁeld (1 m2; under low
light conditions) and the rat was allowed to leave its cage via a grid
walkway. The latency to emerge from the home cage (i.e., four
paws on the grid) was scored. If the rat did not emerge from its
home cage within 300 s, the session was ended, the home cage was
closed again and the rat was given a score of 300 s. The scores of
3 trials carried out on 3 consecutive days were averaged (Prickaerts
et al., 1996).
In the forced swimming test (FST), originally designed by Porsolt
et al. (1978), four cylindrical glass tanks (50 cm tall, 20 cm in
diameter) were ﬁlled to a height of 30 cm with 25 1C water. The
movements of the rat were scored automatically with a computer-
ized system (Ethovision Pro, Noldus, The Netherlands) during a
5 min session under low light conditions. Scored were ‘immobility’,
which reﬂects no movement at all and/or minor movements
necessary to keep the nose above the water, and ‘strong mobility’,
reﬂecting ‘escape behavior’ (e.g. climbing against the walls and
diving). Settings within Ethovision were adjusted based on manually
recorded sessions and were attuned for each sex separately
(immobility/mobility threshold: 12 and 20; mobility/strong mobility
threshold: 16.5 and 23.9 for males and females, respectively;
Strackx et al., 2009).
The sucrose intake (SI) test was used to examine anhedonia
(Willner et al., 1992; Dalla et al., 2005; Gronli et al., 2005). Rats
were allowed to acclimatize to a 1% sucrose solution 2 days before
the actual experiment. At 5.00 h on the test day, at the start of the
dark phase, rats were deprived of food and water for 14 h. At
19.00 h, i.e., 2 h after the lights had turned on a 1% sucrose solution
was offered. After 1 h sucrose consumption was measured and the
intake was expressed in ml 1% sucrose/kg body weight consumed to
control for intake differences due to possible differences in body
weight (Dalla et al., 2005; Gronli et al., 2005).2.3. Corticosterone response and radioimmuno-assay
To test the HPA axis responsivity, rats were individually placed in a
type II (mouse) cage ﬁlled with 500 ml 25 1C water. Experiments
were performed in an isolated room between 13.00 and 15.00 h.
Immediately after taking the rat from its home cage, a ﬁrst blood
sample was collected via a saphenous vein puncture representing
the basal corticosterone level. Immediately after this ﬁrst sample
was taken, the rat was put in the cage ﬁlled with water for 20 min
after which a second blood sample was taken. Afterwards, the
animal was returned to its home cage and left undisturbed for
40 min after which a ﬁnal blood sample was taken. Blood samples
were kept on ice and centrifuged at 5000 rpm for 10 min at 4 1C,
after which the plasma was frozen down to 75 1C for subsequent
determination of corticosterone levels (in duplicate). For this
purpose, 50 ml of plasma was extracted with 3 ml dichloromethane
and vortexed for 1 min. Corticosterone was subsequently measured
directly on 1 ml dried dichloromethane and extracted for radio-
immunoassay using corticosterone–125I. The radioimmunological
reaction was performed overnight at 4 1C, after which a second
antibody system was used to separate bound and unbound steroid as
previously described in detail (Sulon et al., 1978). The average
intra- and inter-assay coefﬁcients of variation for all assays were
below 10%. The assay had a sensitivity of 7.7 ng/mL.2.4. RNA preparation
Total RNA was extracted using RNeasy Mini kits (QIAGEN, Venlo, The
Netherlands). Glass beads of 1 mm together with buffer RLT
(provided by the RNeasy Mini kit) were added to the frozen tissues,
and subsequently homogenized in a Minibead Beater (Biospec
Products, OK, USA). After removal of cellular debris by centrifuga-
tion, extraction was continued according to instructions of the
RNeasy Mini kit.
2.5. Microarray hybridization
Analysis of whole genome expression was performed at the facilities
of ServiceXS (Leiden, The Netherlands). Quality of RNA samples was
assessed by electrophoresis using the Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA, USA). Of each experimental
group four pools of three samples were prepared. Pools were
subsequently hybridized on the RatRef-12 Expression BeadChip
(Illumina, San Diego, CA, USA).
2.6. Data normalization
Normalization of expression data was performed as previously
described (Alttoa et al., 2010). In summary, the raw microarray
data were processed using the Beadarray (Dunning et al., 2007)
PreprocessCore (Bolstad et al., 2003) and PUMA (Sanguinetti et al.,
2006) R packages of bioconductor (Bioconductor). In the Beadarray
package the BackgroundCorrect method used was ‘‘minimum’’,
whilst variables for the CreatebeadsummaryData method were as
follows: log=TRUE, n=10. Data were normalized using the quantile
normalization algorithm from the PreprocessCore package. An
important outcome measure of the PUMA analysis is the Probability
of Positive Log Ratio (pplr) statistic, a probability measure of
differential expression that considers uncertainty of expression
levels. Statistically signiﬁcant differentially expressed genes were
deﬁned as genes with a minimum pplr value (the minimum of pplr or
1pplr) less than 0.001. As such, separate sets of differentially
expressed genes between control and PS animals for each gender
and brain region (hippocampus and FC) were generated.
2.7. Microarray data analysis
To ﬁnd signiﬁcantly over-represented molecular pathways within the
sets of genes differentially regulated by PS, we searched the pathway
database of the Kyoto Encyclopedia of Genes and Genomes (KEGG)
using the DAVID Functional Annotation Tool (http://david.abcc.
ncifcrf.gov/, see also (Huang da et al., 2009)). The KEGG pathway
database is a collection of manually drawn graphical diagrams that
represent the current knowledge of molecular interactions involved in
various cellular processes (http://www.genome.ad.jp/kegg/pathway.
html). The DAVID tool produces a gene enrichment score (EASE score,
which is a modiﬁed Fisher Exact p-value) for each KEGG pathway. For
identifying signiﬁcant enriched pathways the cut-off value was set at
Po0.05. Additionally, the lists of differentially expressed genes were
manually screened to identify genes encoding proteins, known to be
implicated in signaling pathways in the pathophysiology and/or
treatment of mood disorders.
2.8. Statistical analysis
EZM, FST and SI data were explored by using a two-way ANOVA (sex x
condition). In addition, since all of these tests displayed either a
signiﬁcant sex x condition interaction effect and/or highly signiﬁ-
cant sex effects, a stratiﬁed analysis was performed for each sex
separately. For the HCE test, the data were not normally distributed
Figure 1 Percentage of time spent in the open arms of (A) and
total distance moved in (B) the elevated zero maze (EZM). Values
represent means+S.E.M. Male prenatally stressed (PS) rats spent
less time in the open arms of the EZM as compared to control
(C) males. Further, male PS rats covered less distance during the
5 min trial as compared to C males. No differences were observed
between PS and C females. Po0.05 (One-way ANOVA).
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tion period. Therefore, these data were transformed to rank scores,
after which average escape latencies were compared between
groups. Plasma corticosterone values were ln-transformed to nor-
mality. HCE data and corticosterone levels were analyzed by a
repeated measures ANOVA (sex x condition) and also independently
at the different time points using a two-way ANOVA (sex x
condition). Correlation analysis was performed using Pearson’s
correlation coefﬁcient (rp). Statistical signiﬁcance was assumed to
exist at Po0.05, except when studying the effects of PS on
corticosterone levels at the individual time points, in order to
correct for multiple testing (Po0.017). All statistics were carried
out using SPSS software version 12.0.1 (SPSS Inc, USA).
3. Results
3.1. Maternal weight gain, offspring birth weight,
litter size and pre-weaning mortality
Maternal stress exposure in this cohort of animals was
associated with reduced maternal weight gain over gesta-
tion, concomitant with impaired fetal growth in both sexes,
as reported previously (Van den Hove et al., 2010). No
differences were observed in litter size (13.670.9 and
14.170.5 pups per litter for C and PS, respectively) or
pre-weaning mortality (no pups died in either group after
litters had been culled to 8 pups).
3.2. Anxiety- and depression-related behavior
The percentage of time spent in the open arms of the EZM
as well as the distance covered in the EZM are depicted in
Figure 1. An overall sex x condition interaction was
observed (F1,49=6.662; P=0.013) as well as an overall sex-
effect (F1,49=5.983; P=0.018). The overall condition effect
did not reach statistical signiﬁcance (F1,49=2.050; P=0.159).
Stratiﬁed analyses showed that PS male rats spent less time
in the open arms of the EZM as compared to C males (PS
effect: 34.4%, F1,24=7.557; P=0.011). In addition, an
overall sex-effect for the total distance moved in the EZM
was found (F1,49=18.369; Po0.001), whereas there was no
overall condition-effect or sex x condition interaction
(F1,49=1.491; P=0.228 and F1,49=3.587; P=0.064, respec-
tively). Stratiﬁed analysis revealed that male PS rats
covered less distance during the 5 min trial as compared
to C males (PS effect: 25.3%, F1,24=4.970; P=0.035). No
differences were observed between PS and C females in this
respect (F1,25=0.704; P=0.409 for time spent in the open
arms, and F1,25=0.222; P=0.642 for total distance moved).
The average escape latencies in the HCE test are shown in
Figure 2. Over time, a signiﬁcant overall effect for PS was
found (F1,48=6.423; P=0.015) as well as a signiﬁcant sex
effect (F1,48=49.482; Po0.001). The sex x condition inter-
action effect over time, however, failed to reach statistical
signiﬁcance (F1,48=0.031; P=0.860). More speciﬁcally, over
the three trials, male PS rats took more time to leave the
home cage as compared to controls (PS effect: +25.3%,
F1,25=4.863; P=0.037). A similar trend was observed in
female offspring, although this was not signiﬁcance (PS
effect: +33.7%, F1,23=3.026; P=0.095). Results from the
FST are shown in Figure 3. The immobility time did not
show overall PS effects, nor did it show a sex x conditioninteraction (F1,52=0.957; P=0.333 and F1,52=0.309;
P=0.581, respectively). However, a profound overall sex
effect was observed (F1,52=69.658; Po0.001), while strati-
ﬁed analysis per sex revealed no differences between PS
and controls (males: F1,26=0.807; P=0.377; females:
F1,26=0.164; P=0.688). Strong mobility in the FST showed
an overall trend (F1,52=3.239; P=0.078), a highly signiﬁcant
sex effect (F1,52=16.952; Po0.001) and a trend for a sex x
condition interaction (F1,52=3.466; P=0.068). Stratiﬁed
analysis indicated that PS in males resulted in less strong
mobility as compared to controls (PS effect: 21.7%,
F1,26=4.241; Po0.05), whereas no differences in strong
mobility were observed between female groups (F1,26=
0.005; P=0.947). Overall, no differences in SI were observed
between PS and C offspring (F1,24=2.401; P=0134). While
there was no sex x condition interaction (F1,24=0.422;
P=0.522), a signiﬁcant overall sex effect was found
(F1,24=11.158; P=0.003). Stratiﬁed analysis showed no
differences between PS and control offspring in either sex
(males: F1,12=0.619; P=0.447; females: F1,12=1.796;
P=0.205) (Table 1).
Figure 2 Average escape latencies in the home cage emer-
gence (HCE) test. Values represent means (s)+S.E.M. Over the
three trials, male prenatally stressed (PS) rats took more time
to leave the home cage as compared to controls (C). A similar
pattern was observed in female offspring, though this did not
reach statistical signiﬁcance. Po0.05, ]0.05oPo0.10 (ANOVA
based on ranks).
Figure 3 Immobility (A) and strong mobility (B) in the forced
swim test (FST); Values represent means (s)+S.E.M. Whereas no
differences between groups were observed in time spent immobile,
prenatal stress (PS) in males resulted in less strong mobility as
compared to controls (C). No differences in any parameter were
observed between female groups. Po0.05 (One-way ANOVA).
Table 1 Sucrose intake (ml/kg body weight).
Sex Group Sucrose intake
Males C 39.574.7
PS 45.175.4
Females C 56.676.8
PS 70.177.6
Values represent means7S.E.M. Abbreviations: C: control
and PS: prenatal stress. No signiﬁcant differences between
experimental groups were observed.
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Plasma corticosterone levels under basal conditions, immedi-
ately after 20 min of restraint stress, or 40 min after being
placed back into the home cage, are depicted in Figure 4.
Analysis with repeated-measures ANOVA revealed a highly
signiﬁcant change in corticosterone levels over time
(F2,90=128.375; Po0.001; sphericity assumptions met), as
well as a signiﬁcant overall PS effect (F1,45=4.947; P=0.031)
and a highly signiﬁcant overall sex effect (F1,45=33.591;
Po0.001), whereas the sex x condition interaction was not
signiﬁcant (F1,45=0.353; P=0.555). Looking at the three
measurements individually (two-way ANOVA) indicated overall
PS effects for basal corticosterone levels (F1,45=9.871;
P=0.003) and stress levels (F1,45=14.194; Po0.001), both of
which were accompanied by highly signiﬁcant sex differences
(F1,45=40.632; Po0.001 for basal levels and F1,45=73.856;
Po0.001 for stress levels). Overall condition effects for
recovery after stress were, however, not signiﬁcant
(F1,45=2.511; P=0.120) and showed no sex or sex x treatment
interaction effects (F1,45=0.016; P=0.900 and F1,45=0.102;
P=0.751, respectively). Stratiﬁed analysis revealed a signiﬁ-
cant within-subjects effect in males both for time
(F2,50=83.926; Po0.001) and experimental group x time
(F2,50=7.803; P=0.001). In addition, over time, a signiﬁcant
effect of PS was observed (F1,25=4.933; P=0.036). Male PS rats
further showed higher basal plasma corticosterone levels as
compared to controls (PS effect: +108.7%, F1,25=11.568;
P=0.002), whereas stress-induced corticosterone levels were
again lower in male PS rats (PS effect: 21.9%, F1,25=10.183;
P=0.004). In females, a signiﬁcant within-subjects effect was
observed only for time (F2,40=65.937; Po0.001). Further, only
stress-induced plasma corticosterone levels differed between
groups, with PS females showing lower corticosterone levels as
compared to controls (PS effect: 21.6%, F1,20=4.876;
P=0.039). No difference between groups was observed after40 min of recovery (males: F1,25=0.846; P=0.367; females:
F1,20=1.768; P=0.199).3.4. Brain region weights
Weight data of the hippocampus and FC are listed in Table 2.
Relative hippocampal weight was higher in PS females as
Figure 4 Stress-induced corticosterone secretion. Values
represent means (ng/ml)+S.E.M. Male prenatally stressed (PS)
rats showed higher basal plasma corticosterone levels as
compared to controls (C). Stress-induced corticosterone levels
(the grey bar represents a 20 min period of stress) were lower
in both male and female PS offspring. No difference between
groups was observed 40 min after placing the animals back into
their home cage. Po0.05, Po0.01 (One-way ANOVA).
Table 2 Brain region weights (mg/kg body weight).
Sex Group Hippocampus FC
Males C 302.979.8 79.274.7
PS 299.479.8 95.476.4
Females C 485.9714.5 147.175.6
PS 550.1719.8a 164.6715.1
Values represent means7S.E.M. Abbreviations: C: control,
PS: prenatal stress and FC: frontal cortex.
aPo0.05 (Student’s t-test).
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difference between groups was observed in any other case.3.5. Gene expression proﬁles
3.5.1. Differential expression of genes related to stress
and affective behavior
Within the hippocampus, PS affected the expression of 44
and 1084 genes in male and female offspring, respectively.
Within the FC, 114 and 688 genes were expressed differen-
tially by PS in male and female offspring, respectively.
An overview of all genes regulated by PS exposure within
the hippocampus and FC of male offspring is given in
Tables 3 and 4, respectively. Individual genes regulated
in the hippocampus and FC of female offspring is depicted in
Supplemental Material S1 and S2.3.5.2. Pathway analyses
DAVID–KEGG analysis showed that in male offspring no KEGG
pathways were signiﬁcantly enriched by PS within any of the
brain regions, which was related to the limited number ofgenes affected by PS in male offspring. Results from the
KEGG pathway analyses on gene expression proﬁles within
the female hippocampus and FC are depicted in Tables 5
and 6, respectively. Within the hippocampus, ‘cell adhesion
molecules (CAMs)’, ‘ErbB signaling pathway’, ‘focal adhe-
sion’, ‘insulin signaling pathway’, ‘long term potentiation’,
‘mTOR signaling pathway’, ‘phosphatidylinositol (PI) signal-
ing system’, and ‘tight junction’ were signiﬁcantly changed
after PS. Within the FC, the KEGG pathways ‘ribosome’ and
‘Wnt-signaling’ were signiﬁcantly affected by PS. In addi-
tion, manual browsing of the gene lists for candidate genes
encoding proteins known to be involved in the pathophy-
siology and/or treatment of affective disorders revealed
several differentially expressed genes involved in glutamate
and gamma-aminobutyric acid (GABA) neurotransmission,
cyclic adenosine monophosphate (cAMP)/ cyclic guanosine
monophosphate (cGMP)/ phosphodiesterase (PDE) signaling,
and epigenetic regulation, in both the hippocampus and FC
of male and female PS offspring (see Table 7). An overview
on relevant signaling cascades altered within the female
hippocampus and FC, based on the expression proﬁles
and subsequent functional clustering using DAVID is given
in Figure 5.
4. Discussion
As a hypothesis-generating approach, in order to gain more
insight into the molecular mechanisms that mediate the
behavioral effects of developmental stress exposure, we
examined the enduring effects of PS exposure on gene
expression proﬁles within the hippocampus and FC of adult
male and female Sprague-Dawley rats. While PS increased
anxiety- and depression-related behavior particularly in
male Sprague-Dawley rats, female offspring seemed to be
relatively resilient to PS exposure. In addition, PS altered
the expression of numerous genes in the hippocampus and
FC in a sex-speciﬁc manner. These sex-speciﬁc alterations
may, at least in part, explain the behavioral differences
observed between both sexes, i.e. relative vulnerability
versus resilience to PS in male versus female rats,
respectively.
4.1. Sex differences in behavior and the response
to stress
PS resulted in a signiﬁcant increase in anxiety- and
depression-related behavior in male offspring, while beha-
vior in females was largely unaffected. In addition, only
male PS offspring showed clearly increased basal plasma
corticosterone levels, whereas PS offspring of both sexes
failed to show an adequate response to stress. Among
females, adult hippocampal weight was relatively increased
after PS.
Although the overall prevalence of mood disorders is
higher in female as compared to male humans (Blehar,
1995), a different pattern seems to be observed in
PS-related psychopathology (Darnaudery and Maccari,
2007). Whereas only male PS Sprague-Dawley rats showed
a clear increase in anxiety- and depression-related behavior,
PS females seemed to remain relatively resilient to PS
exposure in the present study. Studies by the group of
Table 3 Genes differentially regulated by PS exposure in the male hippocampus, sorted by fold change.
Entrez symbol Entrez
gene ID
Gene name Transcript Probe ID Fold
change
Mrpl18_predicted 292244 mitochondrial ribosomal protein L18 ILMN_54513 ILMN_1359180 5.46
Sc5dl 114100 sterol-C5-desaturase (ERG3 delta-5-desaturase
homolog, S. cerevisiae)-like
ILMN_263006 ILMN_1363277 2.59
Rbj 298859 rab and DnaJ domain containing ILMN_278305 ILMN_1355125 1.31
Kcnab2 29738 potassium voltage-gated channel, shaker-related
subfamily, beta member 2
ILMN_267848 ILMN_1355212 1.28
mrpl11 293666 mitochondrial ribosomal protein L11 ILMN_291563 ILMN_1363330 1.28
Ttyh3_predicted 304315 tweety homolog 3 (Drosophila) ILMN_272392 ILMN_1651087 1.27
Trrap_predicted 288471 transformation/transcription domain-associated
protein
ILMN_267735 ILMN_1360742 1.25
Hdac4_predicted 363287 histone deacetylase 4 ILMN_266642 ILMN_1364573 1.24
LOC361990 361990 similar to DKFZP547E1010 protein; similar to Protein
C1orf77 homolog
ILMN_66762 ILMN_1650076 1.21
Thg1l 303067 tRNA-histidine guanylyltransferase 1-like
(S. cerevisiae)
ILMN_286909 ILMN_1649860 1.20
RGD1307814_predicted 362559 zyg-11 homolog B (C. elegans) ILMN_278965 ILMN_1375196 1.19
Rhcg 293048 Rh family, C glycoprotein ILMN_281613 ILMN_1361451 1.19
RGD1565184_predicted 502705 similar to VEPH isoform A ILMN_48005 ILMN_1530385 1.17
LOC501534 501534 NA ILMN_66173 ILMN_1360820 1.16
RGD1566402_predicted 500127 homeo box A10 ILMN_285373 ILMN_1354843 1.16
Farsb 301544 phenylalanyl-tRNA synthetase, beta subunit ILMN_265522 ILMN_1356564 1.15
Ibrdc2_predicted 364681 ring ﬁnger protein 144B ILMN_291094 ILMN_1366789 1.15
Lgals7 29518 lectin, galactoside-binding, soluble, 7 ILMN_297724 ILMN_1376402 1.15
Mrc2_predicted 295631 phospholipase A2 receptor 1 ILMN_277146 ILMN_1358009 1.15
Spn 24796 Sialophorin ILMN_279075 ILMN_1361495 1.15
Dnajc11_predicted 362666 DnaJ (Hsp40) homolog, subfamily C, member 11 ILMN_62144 ILMN_1361685 1.14
Sbk1 113907 similar to SH3-binding kinase; SH3-binding domain
kinase 1
ILMN_284727 ILMN_1353425 1.14
LOC503147 503147 similar to FLJ45949 protein ILMN_66420 ILMN_1361222 1.13
Wdr7 66031 WD repeat domain 7 ILMN_290962 ILMN_1351953 1.13
LOC500878 500878 similar to LRRGT00057 ILMN_48959 ILMN_1372001 1.11
Calr3_predicted 364529 calreticulin 3 ILMN_48314 ILMN_1375963 0.89
Dhh 84380 desert hedgehog homolog (Drosophila) ILMN_53576 ILMN_1370554 0.89
Mif 81683 macrophage migration inhibitory factor (MIF) ILMN_264813 ILMN_1356539 0.89
Olr1491_predicted 404969 olfactory receptor 1491 ILMN_277212 ILMN_1359277 0.89
Aspn 306805 asporin ILMN_285309 ILMN_1369408 0.88
Pik3c2g 116720 phosphoinositide-3-kinase, class 2,
gamma polypeptide
ILMN_273653 ILMN_1349959 0.88
Lhx6_predicted 311901 LIM homeobox 6 ILMN_60425 ILMN_1352539 0.87
Ufd1l 84478 ubiquitin fusion degradation 1 like (yeast) ILMN_49407 ILMN_1372253 0.87
Sema6b 84609 sema domain, transmembrane domain (TM), and
cytoplasmic domain, (semaphorin) 6B
ILMN_288957 ILMN_1650011 0.86
Limk1 65172 LIM domain kinase 1 ILMN_286066 ILMN_1372778 0.85
Traf3ip3 360900 TRAF3 interacting protein 3 ILMN_287167 ILMN_1365920 0.85
Olr556 405249 olfactory receptor 557; olfactory receptor 556 ILMN_269876 ILMN_1373130 0.84
Timm9 171139 translocase of inner mitochondrial membrane
9 homolog (yeast)
ILMN_271875 ILMN_2039665 0.83
Gnl3 290556 guanine nucleotide binding protein-like 3 (nucleolar);
similar to guanine nucleotide binding protein-like 3
(nucleolar)
ILMN_263704 ILMN_1357924 0.80
Mrps2_predicted 362094 mitochondrial ribosomal protein S2 ILMN_50349 ILMN_1365807 0.80
Prim2 301323 primase, DNA, polypeptide 2 ILMN_270579 ILMN_1355020 0.80
Arsb 25227 arylsulphatase B ILMN_58825 ILMN_1366780 0.73
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Table 4 Genes differentially regulated by PS exposure in the male FC, sorted by fold change.
Symbol Entrez
gene ID
Gene name Transcript Probe ID Fold
change
Mrpl18_predicted 292244 mitochondrial ribosomal protein L18 ILMN_54513 ILMN_1359180 6.40
Sc5dl 114100 sterol-C5-desaturase (ERG3 delta-5-desaturase
homolog, S. cerevisiae)-like
ILMN_263006 ILMN_1363277 2.00
C4–2 406161 complement component 4, gene 2 ILMN_271471 ILMN_1361837 1.31
Txnip 117514 thioredoxin interacting protein ILMN_280023 ILMN_1359696 1.29
Prim1 246327 DNA primase, p49 subunit ILMN_271101 ILMN_1353345 1.28
Gng11 64199 guanine nucleotide binding protein (G protein),
gamma 11
ILMN_62822 ILMN_1354189 1.25
Plac8_predicted 360914 placenta-speciﬁc 8 ILMN_292070 ILMN_1363160 1.24
Tmem140 362334 transmembrane protein 140 ILMN_278563 ILMN_1372260 1.24
Cyyr1 304138 cysteine/tyrosine-rich 1 ILMN_287228 ILMN_1374917 1.22
Iﬁtm3 361673 interferon induced transmembrane protein 3 ILMN_265471 ILMN_1352762 1.22
Heph 117240 Hephaestin ILMN_269859 ILMN_1371544 1.21
Lcp1 306071 lymphocyte cytosolic protein 1 ILMN_279425 ILMN_1376765 1.20
Commd9 295956 COMM domain containing 9 ILMN_270917 ILMN_1370105 1.19
LOC309349 309349 SLIT and NTRK-like family, member 2 ILMN_65982 ILMN_1357725 1.19
Cyba 79129 cytochrome b-245, alpha polypeptide ILMN_279326 ILMN_1366276 1.18
Gpm6a 306439 glycoprotein m6a ILMN_280628 ILMN_1367162 1.18
Loxl1 315714 lysyl oxidase-like 1 ILMN_267667 ILMN_1376846 1.18
Tnfrsf11b 25341 tumor necrosis factor receptor superfamily,
member 11b
ILMN_285163 ILMN_1374220 1.18
Slc37a1 294321 solute carrier family 37 (glycerol-3-phosphate
transporter), member 1
ILMN_297940 ILMN_1376690 1.15
Sox17_predicted 312936 SRY (sex determining region Y)-box 17 ILMN_288748 ILMN_1359017 1.15
Ssg1 64387 coiled-coil domain containing 80 ILMN_59129 ILMN_1362820 1.15
Loxl2_predicted 290350 lysyl oxidase-like 2 ILMN_55682 ILMN_1351352 1.14
Slpi 84386 secretory leukocyte peptidase inhibitor ILMN_270427 ILMN_1360286 1.14
Fxyd5 60338 FXYD domain-containing ion transport regulator 5 ILMN_274559 ILMN_1371590 1.13
Ms4a11_predicted 361735 membrane-spanning 4-domains, subfamily A,
member 11
ILMN_295413 ILMN_1356010 1.13
LOC363259 363259 obscurin-like 1 ILMN_52302 ILMN_1351812 1.12
Ninj2 59115 ninjurin 2 ILMN_289402 ILMN_1370725 1.12
Rdm1_predicted 287726 RAD52 motif 1 ILMN_64467 ILMN_1363012 1.12
RGD1560542_predicted 499847 proline rich Gla (G-carboxyglutamic acid) 4
(transmembrane)
ILMN_277969 ILMN_1650382 1.12
RT1-S2 24994 RT1 class Ib, locus H2-TL-like (S2) ILMN_264682 ILMN_1368215 1.12
Timeless 83508 timeless homolog (Drosophila) ILMN_275078 ILMN_1370013 1.12
LOC497832 497832/
89821
transient receptor potential cation channel,
subfamily C, member 1
ILMN_64900 ILMN_1373735 1.11
RGD1561935_predicted 502180 similar to hypothetical protein 4930474N05 ILMN_283847 ILMN_1367261 1.11
Arhgap21_predicted 307178 Rho GTPase activating protein 21 ILMN_280800 ILMN_1364451 1.10
Hhex 79237 hematopoietically expressed homeobox ILMN_280416 ILMN_1353851 1.10
LOC498331 498331 protein tyrosine phosphatase, non-receptor type 13 ILMN_286408 ILMN_1365973 1.10
Nr1h3 58852 nuclear receptor subfamily 1, group H, member 3 ILMN_269442 ILMN_1352599 1.10
RGD1562979_predicted 305501 similar to DNA-binding protein Ikaros form 1 - mouse ILMN_56783 ILMN_1367066 1.10
LOC364321 364321 similar to T-cell receptor alpha-chain precursor ILMN_65095 ILMN_1649960 1.09
RGD1310868_predicted 303702 endo-beta-N-acetylglucosaminidase ILMN_64738 ILMN_1368424 1.08
Slc9a1 24782 solute carrier family 9 (sodium/hydrogen
exchanger), member 1
ILMN_283430 ILMN_1363067 1.08
Hdgf 114499 hepatoma-derived growth factor ILMN_299659 ILMN_1358138 1.07
RGD1560568_predicted 500914 basic transcription factor 3; similar to basic
transcription factor 3
ILMN_68049 ILMN_1359066 1.06
Hp1bp3 313647 heterochromatin protein 1, binding protein 3 ILMN_297506 ILMN_1362886 0.94
Sf3b2_predicted 293671 splicing factor 3b, subunit 2 ILMN_276631 ILMN_1363457 0.94
RGD1565310_predicted 362697 similar to RIKEN cDNA 1110018J12 ILMN_298926 ILMN_1349900 0.93
Trim27_predicted 291171 tripartite motif-containing 27 ILMN_287365 ILMN_1374685 0.93
Calcb 171519 calcitonin-related polypeptide, beta ILMN_291051 ILMN_1369359 0.92
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Table 4 (continued )
Symbol Entrez
gene ID
Gene name Transcript Probe ID Fold
change
RGD1305500_predicted 308004 similar to hypothetical protein FLJ13188 ILMN_69760 ILMN_1357698 0.92
40428 64551 septin 7 ILMN_277931 ILMN_1370494 0.91
Atp6v1b2 117596 ATPase, H transporting, lysosomal V1 subunit B2 ILMN_265715 ILMN_1360084 0.91
Iqcb1_predicted 303915 IQ motif-containing B1 ILMN_268980 ILMN_1367093 0.91
Ntrk2 25054 neurotrophic tyrosine kinase, receptor, type 2 ILMN_302906 ILMN_1366426 0.91
Oact2 313997 membrane bound O-acyltransferase domain
containing 2
ILMN_287627 ILMN_1373404 0.91
RGD1559475_predicted 498977 similar to dynactin 3; dynactin 3 ILMN_270142 ILMN_1350986 0.91
RGD1564628_predicted 302566 ubiquitin speciﬁc peptidase 27, X-linked ILMN_265296 ILMN_1350769 0.91
Stap1 305269 signal transducing adapter family member 1 ILMN_265181 ILMN_1369894 0.91
Tmem18 362722 transmembrane protein 18 ILMN_291730 ILMN_1367804 0.91
Tsnax 64028 translin-associated factor X ILMN_275146 ILMN_1352444 0.91
Cd19_predicted 365367 CD19 molecule ILMN_55073 ILMN_1367276 0.90
Ddx47 297685 DEAD (Asp-Glu-Ala-Asp) box polypeptide 47 ILMN_282637 ILMN_1350598 0.90
Eif3d 362952 eukaryotic translation initiation factor 3, subunit D ILMN_273976 ILMN_1650977 0.90
Hars2_predicted 362227 D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae) ILMN_61958 ILMN_1364969 0.90
Mrps5_predicted 296134 mitochondrial ribosomal protein S5 ILMN_54617 ILMN_1358174 0.90
Npat_predicted 315666 nuclear protein, ataxia-telangiectasia locus ILMN_56219 ILMN_1366007 0.90
RGD1309216 361726 similar to hypothetical protein FLJ20487 ILMN_269528 ILMN_1361771 0.90
RGD1561681_predicted 498661 similar to Pyruvate kinase isozymes M1/M2
(Pyruvate kinase muscle isozyme)
ILMN_286284 ILMN_1374660 0.90
Tmprss2 156435 transmembrane protease, serine 2 ILMN_280888 ILMN_1353103 0.90
V1ra12 297439 vomeronasal 1 receptor, A12 ILMN_265037 ILMN_1368051 0.90
Bbx_predicted 303970 bobby sox homolog (Drosophila) ILMN_57321 ILMN_1368994 0.89
Chchd4 312559 coiled-coil-helix-coiled-coil-helix domain
containing 4; similar to coiled-coil-helix-coiled-coil-
helix domain containing 4
ILMN_278959 ILMN_1350912 0.89
Foxp1_predicted 297480 forkhead box P1 ILMN_64445 ILMN_1351093 0.89
Ipo9_predicted 304817 importin 9 ILMN_276568 ILMN_1353713 0.89
LOC500936 500936 RGD1560018 ILMN_57948 ILMN_1368595 0.89
Ncor1 54299 nuclear receptor co-repressor 1 ILMN_296119 ILMN_1357958 0.89
RGD1311456_predicted 363089 family with sequence similarity 63, member B ILMN_52033 ILMN_1354049 0.89
RGD1311756_predicted 362769 similar to hypothetical protein FLJ20950 ILMN_263635 ILMN_1356092 0.89
Rp9h_predicted 363032 retinitis pigmentosa 9 (human) ILMN_266474 ILMN_1650578 0.89
Tcf15_predicted 296272 transcription factor 15 ILMN_294039 ILMN_1364142 0.89
Tmem158 117582 transmembrane protein 158 ILMN_282420 ILMN_1371878 0.89
Ash2l_predicted 290829 ash2 (absent, small, or homeotic)-like (Drosophila) ILMN_275112 ILMN_1361125 0.88
Cdk105 171456 similar to TGF beta-inducible nuclear protein 1
(L-name related LNR42); CDK105 protein
ILMN_288993 ILMN_2039008 0.88
Ipmk 171458 similar to inositol polyphosphate multikinase;
inositol polyphosphate multikinase
ILMN_267871 ILMN_1355219 0.88
LOC500483 500483 RGD1559893 ILMN_59110 ILMN_1650108 0.88
Mafb 54264 v-maf musculoaponeurotic ﬁbrosarcoma oncogene
homolog B (avian)
ILMN_272535 ILMN_1361027 0.88
Pscd3 116693 cytohesin 3 ILMN_64245 ILMN_1355570 0.88
Bhlhb2 79431 basic helix-loop-helix family, member e40 ILMN_291562 ILMN_1374180 0.87
Exosc9 294975 exosome component 9 ILMN_281173 ILMN_1362725 0.87
Papola_predicted 314417 poly (A) polymerase alpha ILMN_269256 ILMN_1367021 0.87
Gsk3b 84027 glycogen synthase kinase 3 beta ILMN_283436 ILMN_1349648 0.86
LOC308976 308976 jumonji domain containing 5 ILMN_54422 ILMN_1370490 0.86
Pftk1_predicted 362316 PFTAIRE protein kinase 1 ILMN_57754 ILMN_1355708 0.86
Pou3f2 29588 POU class 3 homeobox 2 ILMN_61074 ILMN_1370881 0.86
Gabra4 140675 gamma-aminobutyric acid (GABA) A receptor, alpha 4 ILMN_282396 ILMN_1363867 0.85
Galnt2_predicted 292090 UDP-N-acetyl-alpha-D-galactosamine:polypeptide
N-acetylgalactosaminyltransferase 2 (GalNAc-T2)
ILMN_287371 ILMN_1355124 0.85
Grm5 24418 glutamate receptor, metabotropic 5 ILMN_292416 ILMN_1361607 0.85
Ktn1_predicted 361029 kinectin 1 ILMN_48977 ILMN_1354299 0.85
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Table 4 (continued )
Symbol Entrez
gene ID
Gene name Transcript Probe ID Fold
change
LOC363410 363410 similar to Ras-related protein Rab-27B ILMN_54002 ILMN_1370567 0.85
LOC500950 500950 zinc ﬁnger protein 317 ILMN_67762 ILMN_1351340 0.85
RGD1311340_predicted 309243 vacuolar protein sorting 13 homolog A (S. cerevisiae) ILMN_65042 ILMN_1372429 0.85
RGD1311723_predicted 363018 similar to KIAA1731 protein ILMN_66607 ILMN_1360056 0.85
Tra1_predicted 362862 tumor rejection antigen gp96 ILMN_284286 ILMN_1376625 0.85
Cpsf2_predicted 299256 cleavage and polyadenylation speciﬁc factor 2 ILMN_49851 ILMN_1373200 0.84
Keap1 117519 Kelch-like ECH-associated protein 1 ILMN_289150 ILMN_1366907 0.83
Kpnb1 24917 karyopherin (importin) beta 1 ILMN_276390 ILMN_1373492 0.83
RGD1562526_predicted 499821 family with sequence similarity 171, member B ILMN_54084 ILMN_1365584 0.82
Grin2a 24409 glutamate receptor, ionotropic, N-methyl
D-aspartate 2A
ILMN_290907 ILMN_1376686 0.81
RGD1561386_predicted 500985 Cas-Br-M (murine) ecotropic retroviral transforming
sequence
ILMN_291557 ILMN_1355687 0.79
Trak2 171086 trafﬁcking protein, kinesin binding 2 ILMN_54675 ILMN_1352978 0.78
LOC497742 497742/
361745
SWI/SNF related, matrix associated, actin dependent
regulator of chromatin, subfamily a, member 2
ILMN_69842 ILMN_1349796 0.77
Arsb 25227 arylsulphatase B ILMN_58825 ILMN_1366780 0.71
Hpcal4 50872 hippocalcin-like 4 ILMN_287235 ILMN_1373628 0.67
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model, i.e. repetitive restraint stress in Sprague-Dawley
rats, illustrate a similar pattern with males showing a more
vulnerable behavioral phenotype (Darnaudery and Maccari,
2007; Zuena et al., 2008). In addition to the increased
vulnerability of males towards, for example, the develop-
ment of an anxious phenotype, their latest study actually
showed PS females to be less anxious as compared to
control female offspring, i.e. two even more distinct
behavioral phenotypes. The more distinct phenotype might
be explained by the fact that Zuena and colleagues started
restraining their pregnant dams from 11 days of gestation
onwards. Furthermore, Zuena et al. (2008) studied the
offspring at a younger age, i.e., 3 months. In line with
these sex-speciﬁc behavioral phenotypes, prenatally
stressed male Sprague-Dawley rats show impaired hippo-
campal plasticity, whereas female rats exposed to PS show
signs of increased structural plasticity (Darnaudery and
Maccari, 2007). Discrepancies between these ﬁndings and
those from other groups may be explained by the use of
other rat strains and/or maternal stress paradigms; an issue
that has already been addressed recently (Zuena et al.,
2008). Further, the age of the offspring studied may play an
important role as well. The sex-dependent effects of PS are
probably related to the sex-speciﬁc timing of relevant
developmental processes over gestation (e.g., Owen and
Matthews, 2003). The exact role of sex in relation to PS
remains to be elucidated though.4.2. Age-related differences in HPA axis
(re-)activity
Similarly, the observed pattern of stress-induced cortico-
sterone secretion in our study was substantially different
from that of other investigations in Sprague-Dawley rats
using the same PS model, but offspring of a different age. Ina study by Morley-Fletcher et al. (2003a) using male
Sprague-Dawley rats of 3 months of age, no effect of PS
on either basal or stress-induced plasma corticosterone
levels was found. In that study, however, recovery after
20 min of restraint stress was weaker after PS. In two other
comparable studies by the same group using male Sprague-
Dawley rats of 2 months of age, both stress-induced plasma
corticosterone levels as well as levels after recovery were
higher in PS animals (Dugovic et al., 1999; Morley-Fletcher
et al., 2003b). An age-dependent relationship between
adverse early-life experience (maternal deprivation) and
HPA axis (re-)activity was already suggested by De Kloet and
Oitzl (2003). Though different in nature, a comparable
phenomenon seems to be involved in HPA axis (re-)activity
after PS. We therefore hypothesize that alterations in HPA
axis (re-)activity per se, rather than just HPA axis hyper-
activity are of importance in relation to PS exposure.4.3. Gene expression proﬁles
Microarray analysis revealed various region- and sex-speciﬁc
effects of PS. Whereas the behavioral effects of PS were
more pronounced in male offspring, gene expression was
altered to a greater extent in female offspring. Relevant
genes affected in male offspring that may explain, at least in
part, the behavioral alterations induced by PS, include those
encoding for Mrpl18 and Sc5dl (both of which were highly
increased in both the hippocampus and FC), TrkB (decreased
expression within the FC), hippocalcin (decreased expression
within the FC) and HDAC4 (increased expression within
the hippocampus). Concerning the female offspring, we
hypothesize that the increased number of differentially
expressed genes reﬂects an adaptive response to PS, invol-
ving mechanisms that contribute to resilience to the pro-
depressant effects of PS. Biological processes and/or signal
transduction cascades affected by PS in female offspring
Table 5 KEGG pathways and associated genes regulated by PS exposure in the female hippocampus.
Entrez symbol Entrez
gene ID
Gene name Transcript Probe ID Fold
change
Cell adhesion molecules (CAMs)
Alcam 79559 activated leukocyte cell adhesion molecule ILMN_298443 ILMN_1370154 0.34
Cd226_predicted 307199 cd226 antigen (predicted) ILMN_58791 ILMN_1350388 1.14
Cd276 315716 b7 homolog 3 ILMN_61049 ILMN_1360321 1.36
Cd80 25408 cd80 antigen ILMN_300031 ILMN_1353891 1.15
Cldn10_predicted 290485 claudin 10 (predicted) ILMN_272711 ILMN_1358030 0.70
Cldn5 65131 claudin 5 ILMN_63515 ILMN_1352195 1.19
Cntn2 25356 contactin 2 ILMN_295743 ILMN_1367489 1.35
Itga6 114517 integrin; alpha 6 ILMN_285522 ILMN_1351793 0.78
Ncam1 24586 neural cell adhesion molecule 1 ILMN_284523 ILMN_1370085 0.48
Negr1 59318 neuronal growth regulator 1 ILMN_289426 ILMN_1366196 0.39
Nlgn1 116647 neuroligin 1 ILMN_298217 ILMN_1364761 1.27
Nrxn1 60391 neurexin 1 ILMN_263241 ILMN_1369278 0.53
Pdcd1_predicted 301626 programmed cell death 1 (predicted) ILMN_269125 ILMN_1357025 1.16
RT1-Ba 309621 butyrophilin-like 2 (mhc class ii associated) ILMN_302329 ILMN_1376669 1.48
RT1-S3 294228 rt1 class ib; locus bm1 ILMN_275620 ILMN_1371428 1.47
Sdc4 24771 syndecan 4 ILMN_284660 ILMN_1352387 1.36
ErbB signaling
Camk2b 24245 calcium/calmodulin-dependent protein kinase ii
beta subunit
ILMN_295816 ILMN_1367246 0.37
Cblb 171136 casitas b-lineage lymphoma b ILMN_290443 ILMN_1351226 0.50
Crk 54245 v-crk sarcoma virus ct10 oncogene homolog (avian) ILMN_265349 ILMN_1361978 0.68
Egf 25313 epidermal growth factor ILMN_284600 ILMN_1371224 1.15
Egfr 24329 epidermal growth factor receptor ILMN_268935 ILMN_1362571 0.79
Elk1 314436 elk1; member of ets oncogene family ILMN_56253 ILMN_1651026 0.71
Kras 24525 kirsten rat sarcoma viral oncogene homolog 2 (active) ILMN_284143 ILMN_1373027 0.65
Map2k2 58960 mitogen activated protein kinase kinase 2 ILMN_273342 ILMN_1362844 1.32
Mapk1 116590 mitogen activated protein kinase 1 ILMN_267006 ILMN_1349290 0.66
Pak3 29433 p21 (cdkn1a)-activated kinase 3 ILMN_283805 ILMN_1373238 0.40
Pik3cb 85243 phosphatidylinositol 3-kinase; catalytic; beta
polypeptide
ILMN_296182 ILMN_1368644 0.82
Pik3r3 60664 phosphatidylinositol 3 kinase; regulatory subunit;
polypeptide 3
ILMN_268148 ILMN_1358018 0.57
Rps6kb2 361696 ribosomal protein s6 kinase; polypeptide 2 ILMN_275356 ILMN_1370952 1.29
Focal adhesion
Actg_predicted 287876 actin; gamma; cytoplasmic ILMN_55178 ILMN_1362269 0.78
Cav1 25404 caveolin ILMN_288688 ILMN_1376388 0.63
Crk 54245 v-crk sarcoma virus ct10 oncogene homolog (avian) ILMN_265349 ILMN_1361978 0.68
Egf 25313 epidermal growth factor ILMN_284600 ILMN_1371224 1.15
Egfr 24329 epidermal growth factor receptor ILMN_268935 ILMN_1362571 0.79
Elk1 314436 elk1; member of ets oncogene family ILMN_56253 ILMN_1651026 0.71
Flnb_predicted 306204 ﬁlamin; beta (predicted) ILMN_64302 ILMN_1362723 0.83
Itga10_predicted 310683 integrin; alpha 10 (predicted) ILMN_274071 ILMN_1373558 1.18
Itga6 114517 integrin; alpha 6 ILMN_285522 ILMN_1351793 0.78
Mapk1 116590 mitogen activated protein kinase 1 ILMN_267006 ILMN_1349290 0.66
Pak3 29433 p21 (cdkn1a)-activated kinase 3 ILMN_283805 ILMN_1373238 0.40
Pdgfd 66018 platelet-derived growth factor; d polypeptide ILMN_299016 ILMN_1352347 0.90
Pdpk1 81745 3-phosphoinositide dependent protein kinase-1 ILMN_276807 ILMN_1359177 0.28
Pik3cb 85243 phosphatidylinositol 3-kinase; catalytic; beta
polypeptide
ILMN_296182 ILMN_1368644 0.82
Pik3r3 60664 phosphatidylinositol 3 kinase; regulatory subunit;
polypeptide 3
ILMN_268148 ILMN_1358018 0.57
Vtn 29169 vitronectin ILMN_291791 ILMN_1374141 1.29
Insulin signaling
Acaca 60581 acetyl-coenzyme a carboxylase alpha ILMN_264748 ILMN_1374107 0.78
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Entrez symbol Entrez
gene ID
Gene name Transcript Probe ID Fold
change
Cblb 171136 casitas b-lineage lymphoma b ILMN_290443 ILMN_1351226 0.50
Crk 54245 v-crk sarcoma virus ct10 oncogene homolog (avian) ILMN_265349 ILMN_1361978 0.68
Elk1 314436 elk1; member of ets oncogene family ILMN_56253 ILMN_1651026 0.71
Ins1 24505 insulin 1 ILMN_66664 ILMN_1370839 1.13
Kras 24525 kirsten rat sarcoma viral oncogene homolog 2 (active) ILMN_284143 ILMN_1373027 0.65
Map2k2 58960 mitogen activated protein kinase kinase 2 ILMN_273342 ILMN_1362844 1.32
Mapk1 116590 mitogen activated protein kinase 1 ILMN_267006 ILMN_1349290 0.66
Pdpk1 81745 3-phosphoinositide dependent protein kinase-1 ILMN_276807 ILMN_1359177 0.28
Pik3cb 85243 phosphatidylinositol 3-kinase; catalytic; beta
polypeptide
ILMN_296182 ILMN_1368644 0.82
Pik3r3 60664 phosphatidylinositol 3 kinase; regulatory subunit;
polypeptide 3
ILMN_268148 ILMN_1358018 0.57
Rps6kb2 361696 ribosomal protein s6 kinase; polypeptide 2 ILMN_275356 ILMN_1370952 1.29
Long-term potentiation (LTP)
Camk2b 24245 calcium/calmodulin-dependent protein kinase ii
beta subunit
ILMN_295816 ILMN_1367246 0.37
Gnaq 81666 guanine nucleotide binding protein; alpha q
polypeptide
ILMN_280496 ILMN_1355584 0.48
Grm5 24418 glutamate receptor; metabotropic 5 ILMN_292416 ILMN_1361607 0.71
Kras 24525 kirsten rat sarcoma viral oncogene homolog 2 (active) ILMN_284143 ILMN_1373027 0.65
LOC317203 317203 similar to ribosomal protein s6 kinase polypeptide 6 ILMN_68494 ILMN_1374028 0.82
Map2k2 58960 mitogen activated protein kinase kinase 2 ILMN_273342 ILMN_1362844 1.32
Mapk1 116590 mitogen activated protein kinase 1 ILMN_267006 ILMN_1349290 0.66
Ppp3ca 24674 protein phosphatase 3; catalytic subunit; alpha isoform ILMN_271084 ILMN_1372414 0.45
mTOR signaling
Ins1 24505 insulin 1 ILMN_66664 ILMN_1370839 1.13
LOC317203 317203 similar to ribosomal protein s6 kinase polypeptide 6 ILMN_68494 ILMN_1374028 0.82
Mapk1 116590 mitogen activated protein kinase 1 ILMN_267006 ILMN_1349290 0.66
Pdpk1 81745 3-phosphoinositide dependent protein kinase-1 ILMN_276807 ILMN_1359177 0.28
Pik3cb 85243 phosphatidylinositol 3-kinase; catalytic;
beta polypeptide
ILMN_296182 ILMN_1368644 0.82
Pik3r3 60664 phosphatidylinositol 3 kinase; regulatory subunit;
polypeptide 3
ILMN_268148 ILMN_1358018 0.57
Rps6kb2 361696 ribosomal protein s6 kinase; polypeptide 2 ILMN_275356 ILMN_1370952 1.29
Phosphatidylinositol (PI) signaling
Impa1 83523 inositol (myo)-1(or 4)-monophosphatase 1 ILMN_302173 ILMN_1364531 0.85
LOC497681 25666/
497681
diacylglycerol kinase, gamma ILMN_56964 ILMN_1363234 0.43
Pik3c2a_predicted 361632 phosphatidylinositol 3-kinase; c2 domain containing;
alpha polypeptide (predicted)
ILMN_264548 ILMN_1361702 0.57
Pik3c2g 116720 phosphatidylinositol 3-kinase; c2 domain containing;
gamma polypeptide
ILMN_273653 ILMN_1349959 1.14
Pik3cb 85243 phosphatidylinositol 3-kinase; catalytic;
beta polypeptide
ILMN_296182 ILMN_1368644 0.82
Pik3r3 60664 phosphatidylinositol 3 kinase; regulatory subunit;
polypeptide 3
ILMN_268148 ILMN_1358018 0.57
Pip4k2b 89812 phosphatidylinositol-4-phosphate 5-kinase; type ii;
beta
ILMN_291864 ILMN_1349115 0.63
Synj1 85238 synaptojanin 1 ILMN_59553 ILMN_1355054 0.50
Tight junction function
Actg_predicted 287876 actin; gamma; cytoplasmic ILMN_55178 ILMN_1362269 0.78
Cldn10_predicted 290485 claudin 10 (predicted) ILMN_272711 ILMN_1358030 0.70
Cldn5 65131 claudin 5 ILMN_63515 ILMN_1352195 1.19
Epb4.1l1 59317 erythrocyte protein band 4.1-like 1 ILMN_267921 ILMN_1376582 0.81
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Table 5 (continued )
Entrez symbol Entrez
gene ID
Gene name Transcript Probe ID Fold
change
Hcls1 288077 hematopoietic cell speciﬁc lyn substrate 1 ILMN_272174 ILMN_1376482 1.18
Kras 24525 kirsten rat sarcoma viral oncogene homolog 2 (active) ILMN_284143 ILMN_1373027 0.65
Magi2 113970 activin receptor interacting protein 1 ILMN_276385 ILMN_1369780 0.61
Myh13 29605 myosin; heavy polypeptide 13; skeletal muscle ILMN_301178 ILMN_1360194 1.13
Myh3 24583 myosin; heavy polypeptide 3; skeletal muscle;
embryonic
ILMN_302443 ILMN_1360458 1.44
Pard6g_predicted 307237 par-6 partitioning defective 6 homolog gamma
(C. elegans) (predicted)
ILMN_53782 ILMN_1650781 0.85
Prkce 29340 protein kinase c; epsilon ILMN_294755 ILMN_1373193 0.32
D.L.A. Van den Hove et al.1238include glutamatergic and GABAergic neurotransmission,
MAPK/CREB signaling, cAMP/cGMP/PDE signaling, GSK3B
signaling, IP signaling, and central insulin signaling. Further,
epigenetic regulation seemed to be affected to a different
degree in both male and female offspring exposed to PS.
These ﬁndings may indicate new potential therapeutic
targets in the treatment of affective disorders. Below we
will discuss the role of several biological processes in more
detail.4.3.1. Glutamate and GABA
The observed gene expression proﬁles suggest a signiﬁcant role
for glutamatergic neurotransmission in mediating the effects of
PS. For example, female offspring exposed to PS showed a
decrease in the expression of the ionotropic N-methyl
D-aspartate (NMDA) receptors 1 and 2A within the FC, as well
as a decreased metabotropic glutamate receptor 5 (mGluR5)
expression in both the hippocampus and FC. Recent evidence
has suggested that altered glutamatergic neurotransmission,
which may have its origin in early development, plays an
important role in the pathophysiology of mood disorders
(Hashimoto, 2009a, 2009b). Both the NMDA and mGlu receptors
have been proposed as potential therapeutic targets in this
respect (Pilc et al., 2008; Pittenger et al., 2007). Pilc et al.
(2008) suggested a model in which mGlu5 antagonists may
possess antidepressant activity through NMDA receptor block-
ade. Likewise, the observed decrease in mGlu5 receptor
expression within both the hippocampus and FC, together with
the observed decrease in the expression of the NMDA1 and 2A
receptors within the FC of female offspring exposed to PS, may
relate to the resilience towards PS in this sex. Whether
these changes represent a compensatory response to the
decreased expression of glutamic acid decarboxylase (GAD;
decreased in both the hippocampus and FC of PS females), the
enzyme that catalyzes the decarboxylation of glutamate to
GABA, remains to be elucidated. In a recent investigation by
Zuena et al. (2008), PS was shown to result in a reduction in
mGlu5 receptor protein levels within the hippocampus of male
offspring only. These rats further showed increased anxiety-
related behavior. In contrast, female PS rats in that same study
displayed reduced anxiety and no change in mGlu5 receptor
levels in the hippocampus. The authors suggested that the
decrease in mGlu receptor function observed in PS male rats
represents ‘‘an unsuccessful homeostatic mechanism aimed atrestoring the physiological levels of the anxiety response’’
(Zuena et al., 2008). Though mRNA expression is markedly
different from protein expression, the discrepancy between
their study and ours may further be explained by the fact that
the rats used in our study are older as compared to those in the
study by Zuena et al. (2008).
Closely related to glutamate function is the role of the
inhibitory neurotransmitter GABA and its receptors. Dys-
function of the GABAergic neurotransmitter system has
recently been associated with the development of both
mood and anxiety disorders (Kalueff and Nutt, 2007; Price
et al., 2009). Moreover, in both human and animal studies,
positive modulators of GABAergic neurotransmission gener-
ally exert anxiolytic and antidepressant effects, while
negative modulators possess anxiogenic- or depressive-like
activity (Kalueff and Nutt, 2007). It is known that stress as
well as many GABAergic psychotropic drugs is both capable
of affecting GABA receptor subunit composition, which in
turn may dramatically affect its functions (Zhang et al.,
1998). Similarly, the expression of multiple GABAergic
receptor subunits was affected after PS in the present
study. For example, within the FC of male offspring, the
expression of the alpha 4 subunit was decreased in PS as
compared to control animals. Within females, the expres-
sion of various GABA receptor subunits was affected by PS in
both brain regions. Further, as mentioned above, the
expression of GAD was decreased in both the hippocampus
and FC of PS females.
Altogether, these data suggest that changes in glutama-
tergic and GABAergic neurotransmission may play a promi-
nent role in the regulation of affective state and reiterate
the need for further research on their possible therapeutic
value in disorders like anxiety and depression.4.3.2. Ribosome function
The Mrpl18 gene encodes a 39S subunit protein that belongs
to the L18P ribosomal protein family, the exact function of
which remains largely unknown. Recently though, Mrpl18
has been shown to play a key role in mediating import of the
nuclear DNA-encoded 5S rRNA into mitochondria, by which
5S rRNA molecules can be speciﬁcally withdrawn from the
cytosolic pool and redirected to mitochondria, bypassing
the classic nucleolar reimport pathway (Smirnov et al.,
2011). The profound increase in Mrpl18 mRNA expression in
Table 6 KEGG pathways and associated genes regulated by PS exposure in the female FC.
Entrez symbol Entrez
gene ID
Gene name Transcript Probe ID Fold
change
Ribosome function
LOC501605 501605 ribosomal protein s2 ILMN_68333 ILMN_1364624 1.60
LOC684988 684988 ribosomal protein s13 ILMN_263434 ILMN_1351503 1.24
LOC690364 690364 ribosomal protein l21 ILMN_274137 ILMN_1363975 1.23
RGD1563431_predicted 501876 large subunit ribosomal protein l36a ILMN_296283 ILMN_2040666 1.25
RGD1564290_predicted 498837 ribosomal protein s27a ILMN_68667 ILMN_1362582 1.16
Rpl18a 290641 similar to 60s ribosomal protein l18a ILMN_285160 ILMN_1370927 1.25
Rpl24 64307 ribosomal protein l24 ILMN_283110 ILMN_1353774 1.18
Rpl37 81770 ribosomal protein l37 ILMN_284909 ILMN_1354107 1.33
Rpl7 297755 ribosomal protein l7 ILMN_281851 ILMN_1370118 1.29
Rps11 81774 ribosomal protein s11 ILMN_288262 ILMN_1373412 1.25
Rps23 124323 ribosomal protein s23 ILMN_263631 ILMN_1369998 1.61
Rps7 29258 ribosomal protein s7 ILMN_62060 ILMN_1650594 1.26
Rps8 65136 ribosomal protein s8 ILMN_266152 ILMN_1362384 1.11
Wnt signaling
Camk2b 24245 calcium/calmodulin-dependent protein
kinase ii beta subunit
ILMN_295816 ILMN_1367246 0.81
Camk2g 171140 calcium/calmodulin-dependent protein
kinase ii gamma
ILMN_290091 ILMN_1364240 0.88
Chd8 65027 beta-catenin binding protein ILMN_53502 ILMN_1363589 0.80
Ctnnb1 84353 catenin (cadherin associated protein);
beta 1; 88 kda
ILMN_297571 ILMN_1352752 1.31
Cxxc4 83824 cxxc ﬁnger 4 ILMN_273940 ILMN_1350191 0.85
Gsk3b 84027 glycogen synthase kinase 3 beta ILMN_283436 ILMN_1349648 0.81
Lrp6_predicted 312781 low density lipoprotein receptor-
related
protein 6 (predicted)
ILMN_278789 ILMN_1349678 0.86
Map3k7_predicted 313121 mitogen activated protein kinase kinase
kinase 7 (predicted)
ILMN_265678 ILMN_1371190 1.16
Ppard 25682 peroxisome proliferator activated
receptor delta
ILMN_272514 ILMN_1357865 0.88
Ppp3cb 24675 protein phosphatase 3; catalytic
subunit;
beta isoform
ILMN_263806 ILMN_1351926 1.22
1239Vulnerability versus resilience to PS in male and female ratsboth the hippocampus and FC of PS male offspring, in
addition to the altered expression of related genes,
e.g. Mrpl11 and Mrps2 (both in FC), as well as Mrps5 and
Ms4a11 (both in hippocampus) suggests a dysregulated
transport of 5s rRNA and associated ribosomal function.
Interestingly, PS increased the expression of numerous
genes encoding ribosomal proteins in the FC of female
offspring (13 differentially expressed, all of which increased
by PS exposure). This suggests that the brain is increasing its
capacity for protein synthesis, which could be interpreted
as an attempt to compensate for impaired cytosolic transla-
tion (Bonow et al., 2009).4.3.3. MAPK/CREB/neurotrophic factor signaling and
hippocalcin
DAVID analysis showed a substantial overall negative effect
of PS on MAPK signaling within the female hippocampus.
Examples of genes downregulated by PS within this brain
region were genes for the rat sarcoma viral oncogenehomolog 2 (RAS), calcineurin (CaN), MAPK 1 (or ERK2),
MAPK kinase kinase 1 (MAP3K1 or MEKK1), and ribosomal s6
kinase (RSK). Furthermore, the expression of the gene
encoding for MAPK phosphatase-4 (MKP4), also known as
dual speciﬁcity phosphatase 9 (DUSP9), which is known to
deactivate MAPK, was increased in PS females.
A major substrate for the ERK/MAPK signaling pathway is
the transcription factor CREB, which regulates the expres-
sion of, e.g. BDNF and is known to play an important role in
mediating the antidepressant effects of neurotrophic fac-
tors and growth factors (Schmidt and Duman, 2011; Tanis
et al., 2007). Interestingly, impaired function of BDNF and
its receptor, the tyrosine kinase B (TrkB) receptor, have
been linked to the development of major depression as well
as a diminished response to antidepressant drugs (Dong
et al., 2009; Duman and Monteggia, 2006; Tanis and Duman,
2007; Tanis et al., 2007). In the present study, Ntrk2 gene
expression (which encodes the TrkB receptor) was
decreased by PS in the FC of male offspring. CREB signaling
can also be induced by Ca2+-calmodulin-regulated kinases
Table 7 Overview of differentially expressed genes related to glutamatergic and GABAergic neurotransmission,
cAMP/cGMP/PDE signaling, and epigenetic regulation, in the hippocampus and FC of male and female PS offspring.
Entrez symbol Area Sex Entrez
gene ID
Gene name Transcript Probe ID Fold
change
Glutamatergic/ GABAergic neurotransmission
Gabra1 HIP f 29705 gamma-aminobutyric acid (GABA) A
receptor, alpha 1
ILMN_53178 ILMN_1348806 0.60
Gabrb1 HIP f 25450 gamma-aminobutyric acid (GABA) A
receptor, beta 1
ILMN_274145 ILMN_1357628 0.53
Gabbr1 HIP f 81657 gamma-aminobutyric acid (GABA) B
receptor 1
ILMN_60885 ILMN_1354454 0.64
Gad2 HIP f 24380 glutamate decarboxylase 2 ILMN_296357 ILMN_1371012 0.67
Grm5 HIP f 24418 glutamate receptor, metabotropic 5 ILMN_292416 ILMN_1361607 0.71
LOC289606 HIP f 289606 gamma-aminobutyric acid (GABA) A
receptor, alpha 2
ILMN_285601 ILMN_1352358 0.67
Grin2a FC m 24409 glutamate receptor, ionotropic, N-methyl
D-aspartate 2A
ILMN_290907 ILMN_1376686 0.81
Grm5 FC m 24418 glutamate receptor, metabotropic 5 ILMN_292416 ILMN_1361607 0.85
Gabrb1 FC f 25450 gamma-aminobutyric acid (GABA) A
receptor, beta 1
ILMN_274145 ILMN_1357628 0.89
Gad2 FC f 24380 glutamate decarboxylase 2 ILMN_296357 ILMN_1371012 0.63
Grin1 FC f 24408 glutamate receptor, ionotropic, N-methyl
D-aspartate 1
ILMN_283876 ILMN_1365529 0.91
Grin2a FC f 24409 glutamate receptor, ionotropic, N-methyl
D-aspartate 2A
ILMN_290907 ILMN_1376686 0.67
Grm5 FC f 24418 glutamate receptor, metabotropic 5 ILMN_292416 ILMN_1361607 0.75
cAMP/cGMP/PDE signaling
Pde4b HIP f 24626 phosphodiesterase 4B ILMN_295710 ILMN_1353078 0.54
Pde7a HIP f 81744 phosphodiesterase 7A ILMN_60421 ILMN_1353897 0.84
Pde8b HIP f 309962 phosphodiesterase 8B ILMN_276608 ILMN_1348973 0.76
Pde10a HIP f 63885 phosphodiesterase 10A ILMN_283323 ILMN_1361915 0.52
Pde2a FC f 81743 phosphodiesterase 2A ILMN_278143 ILMN_1372916 0.76
Pde4b FC f 24626 phosphodiesterase 4B ILMN_295710 ILMN_1353078 0.76
Epigenetic regulation
Hdac4_predicted HIP m 363287 histone deacetylase 4 ILMN_266642 ILMN_1364573 1.24
Mbd1_predicted HIP f 291439 methyl-CpG binding domain protein 1 ILMN_51671 ILMN_1375594 0.71
Mettl2_predicted HIP f 363687 methyltransferase-like 2 ILMN_48481 ILMN_1370775 0.58
Hdac4_predicted FC f 363287 histone deacetylase 4 ILMN_266642 ILMN_1364573 0.77
Sirt2 FC f 361532 sirtuin 2 (S. cerevisiae) ILMN_281197 ILMN_1352401 1.30
f=female; m=male; HIP=hippocampus; and FC=frontal cortex.
D.L.A. Van den Hove et al.1240(CAMKs), e.g., after stimulation of glutamatergic alpha-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptors (Tanis and Duman, 2007). Interestingly, the
expression of CAMKII was decreased both within the hippo-
campus and FC of PS female as compared to control
offspring. Further, the expression of Gria 3, encoding for
the AMPA3 receptor, was decreased within the FC of PS
females.
Hippocalcin, a member of the neuronal calcium sensor
(NCS) protein family, is another protein involved in CREB
signaling. Hippocalcin-deﬁcient mice display a defect in
CREB activation, associated with impaired spatial and
associative memory (Kobayashi et al., 2005; Noguchi
et al., 2007). In the present study, the expression of
hippocalcin was decreased in the FC of male offspring
exposed to PS, which may reﬂect impaired CREB-signaling
in the FC of these animals.4.3.4. GSK3B signaling
GSK-3B is implicated in the signaling pathways of various
neurotransmitters and growth factors and has a repressing
effect on transcription factors including CREB and B-catenin
(Grimes and Jope, 2001; Salas et al., 2003). GSK-3B has
been implicated in the etiology of various psychiatric
disorders, such as major depression, schizophrenia, and
bipolar disorder (Emamian et al., 2004; Gould et al.,
2004b; Hur and Zhou, 2010; Li and Jope, 2010; Wada,
2009). The mood stabilizer lithium is a selective inhibitor
of GSK-3 (Gould et al., 2004b). Data of rodent studies
suggest that pharmacological inhibition of GSK-3 has
antidepressant-like effects (Gould et al., 2004a;
Kaidanovich-Beilin et al., 2004). In the present study, we
observed a decrease in GSK-3B mRNA expression in the FC of
both male and female PS offspring. In PS females though,
GSK-3B mRNA expression was reduced to a greater extent as
1241Vulnerability versus resilience to PS in male and female ratscompared to PS male offspring. In addition, the expression
of B-catenin, one of the major downstream targets of GSK3B
and the function of which is inhibited by GSK-3B activity,
was increased substantially within the FC of PS females.
Furthermore, the expression of Chd8, the gene encoding for
B-catenin binding protein, which normally binds to
B-catenin thereby inhibiting its function, was decreased,
indicating an even more impaired GSK signaling in PS
females. As such, impaired GSK-3B signaling may represent
another interesting mechanism of action mediating resili-
ence to PS in female offspring.4.3.5. cAMP/cGMP/PDE signaling
Phosphodiesterases (PDEs) are enzymes that degrade the
phosphodiester bond in the second messenger molecules
cyclic adenosine monophosphate (cAMP) and/or cyclic gua-
nosine monophosphate (cGMP) (Bender and Beavo, 2006).
Within the hippocampus of PS female offspring, the expres-
sion of PDE4b, PDE7a, PDE8b and PDE10a was decreased.
In addition, within the FC of PS females, the expression of
PDE2a and PDE4b was reduced.
The inhibition of speciﬁc PDEs, which results in an
increase in cAMP and/or cGMP dependent on the PDE type
being inhibited, offers unique receptor-independent oppor-
tunities to modify cellular processes including apoptosis,
differentiation, lipogenesis, glycogenolysis, gluconeogenesis
and muscle contraction (Halene and Siegel, 2007). Thus,
recently, PDE inhibitors have been identiﬁed as new poten-
tial therapeutics in areas such as dementia, depression, and
schizophrenia (Halene and Siegel, 2007; Reneerkens et al.,
2009; Tanis and Duman, 2007). The majority of the PDEs
affected by PS degrade cAMP only, whereas PDE2 and PDE10
degrade both cAMP and cGMP. The cAMP system mediates
the effect of monoamine neurotransmitters and is known to
be downregulated in the brains of depressed patients (see
review by Tanis and Duman, 2007). The depressive effect of
impaired cAMP signaling is most likely related to the fact
that cAMP activates protein kinase A (PKA), which, in turn,
activates CREB. This notion is supported by the ﬁnding that
chronic blockade of PDE4 with rolipram activates CREB and
increases the expression of BDNF in the hippocampus, and
that rolipram has antidepressant efﬁcacy in both preclinical
and clinical trials (Tanis and Duman, 2007). Along similar
lines, it has been found that PDE4b/ mice exhibited
decreased immobility in the forced swimming test indicat-
ing an antidepressant-like effect (Zhang et al., 2008). PS
male rat offspring in the present study showed increased
depression-related behavior in the forced swimming test,
whereas the behavior of PS female offspring was not
affected as compared to control offspring. Thus, reduced
levels of, e.g., PDE4b, as observed in PS female offspring in
the present study, may explain the lack of depressive-like
behavior in the forced swimming test in this sex after PS
exposure. In this way, a decrease in PDE signaling may lead
to increased cAMP/CREB signaling and related neurotrophic
support. Expression levels of hippocampal PDE10a and FC
PDE2a were reduced in PS females and, therefore, cGMP
might also be of interest in mediating possible protective
effects in PS females in the present study as it has recently
been demonstrated that single nucleotide polymorphisms
(SNPs) located in the genes encoding PDE2a, PDE10a, andthe cGMP-speciﬁc PDE9a gene are associated with major
depression (Wong et al., 2006).
Altogether, these data support the notion that speciﬁc
PDE inhibitors might represent interesting candidates for
possible treatment strategies for disorders such as major
depression.4.3.6. Central insulin signaling
In addition to its well-known role in peripheral glucose
regulation, the hormone insulin has an important role in
regulating central nervous system (CNS) function, the sig-
niﬁcance of which is underscored by the increased vulner-
ability to co-morbidities such as dementia and depression
seen with insulin resistance and diabetes (Brown et al.,
2004; Lustman and Clouse, 2005; McEwen et al., 2002; Ott
et al., 1999). Interestingly, insulin and the insulin receptor
(IR) have been shown to be produced in neurons throughout
the brain (Devaskar et al., 1994; Zhao and Alkon, 2001),
whilst particularly the hippocampus seems to be vulnerable
to chronic hyperglycemia and insulin resistance (Reagan,
2007). The pathophysiological similarities between diabetes
and mood disorders suggest that common mechanistic path-
ways may be involved in the etiology and progression of the
neurological aspects of these disorders. For more informa-
tion on the link between insulin signaling, memory and
mood, (see Reagan, 2007; Robertson et al., 2010). Notably,
our microarray data now also suggest a pivotal role for
central insulin signaling in mediating the effects of PS.
Within the female hippocampus, several genes linked to
insulin and related PI signaling (Yang et al., 2008; Daimon
et al., 2008; Aberg et al., 2006) were differentially
expressed in PS offspring when compared to controls.
Among others, the expression of Ins1, encoding for insulin
itself, was upregulated. In addition, the hippocampal
expression of Slc2a3, the gene encoding glucose transpor-
ter-3, which is responsible for the inﬂux of glucose into
neurons, was decreased in the same offspring. We therefore
hypothesize that enhanced hippocampal insulin signaling in
PS female offspring might represent a compensatory effect
explaining why behavior in females was largely unaffected.4.3.7. Epigenetic regulation
Recently, it has been suggested that epigenetic mechanisms
may account for the symptoms of mental illness and their
(partial) reversal during treatment (Krishnan and Nestler,
2008; McClung and Nestler, 2008; Mill and Petronis, 2007;
Renthal and Nestler, 2009; Tsankova et al., 2007). Evidently,
the use of PS as a developmental rat model for affective
disorders is of particular interest in relation to epigenetic
programming. Speciﬁcally, the endogenously programmed
massive loss and subsequent re-establishment of DNA
methylation in the embryo and fetus comprises diverse
critical periods, during which environmental stimuli can
affect epigenetic regulation (Waterland and Jirtle, 2004). In
this respect, the expression patterns of various genes
involved in epigenetic regulation are remarkable. For
example, the expression of HDAC4 was upregulated within
the hippocampus of PS male offspring, whereas it was
downregulated within the FC of PS females. Other proteins
involved in epigenetic regulation that are affected by PS are
methyltransferase-like 2 and MBD1 (both downregulated
D.L.A. Van den Hove et al.1242within the FC of PS females). Thus, it is likely that changes
in epigenetic regulation in reaction to fetal distress may
contribute to the various physiological and behavioral
changes observed in prenatally stressed subjects. Recent
studies in rodents already provided evidence for epigenetic
programming by early prenatal maternal stress (Bale, 2011;
Darnaudery and Maccari, 2007; Matrisciano et al., 2012;Morley-Fletche et al., 2011; Mueller and Bale, 2008; Zuena
et al., 2008). Interestingly, recently, several studies have
highlighted the antidepressant potential of HDAC inhibitors,
although numerous challenges need to be addressed before
being able to guarantee sufﬁcient speciﬁcity, potency, and a
benign side effect proﬁle of this class of drugs (Covington
et al., 2011; Grayson et al., 2010).
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A major limitation of the present study is that the observed
gene expression patterns may not be directly related to the
behavioral measures assessed in the present study. For
example, the observed changes in gene expression may just
as well be associated with cognitive changes seen with PS
(Zuena et al., 2008). In fact, many of the affected biological
processes are known to be related to various types of
affective and cognitive behavior and may therefore explain
a general increased susceptibility to psychopathology
observed in PS subjects. Furthermore, it is likely that the
behavioral testing paradigms exerted an independent effect
on central gene expression proﬁles. Although behavioral
task exposure was identical for all groups, one cannot
exclude that the animals’ response to it was different
among groups. Thus, behavioral testing may have left a
permanent imprint on hippocampal and frontal gene expres-
sion patterns in a sex- and/or condition-dependent manner.
Obviously, examining behavior and its underlying biological
mechanisms in the same set of animals enables the possi-
bility of linking both features in a more direct way. More-
over, evidently, the use of homogenates does not allow us to
discriminate which speciﬁc anatomical subregions and/or
populations of cells are affected.4.5. Concluding remarks
In conclusion, the present study shows that prenatal mater-
nal stress in Sprague-Dawley rats is associated with clearly
increased anxiety- and depression-related behavior in adult
male, but not female offspring. Male PS offspring further
showed increased basal plasma corticosterone levels,
whereas both PS males and females failed to show an
adequate response to stress with lower stress-induced
corticosterone levels as compared to controls. While the
behavioral effects of PS were more pronounced in male
offspring, gene expression was altered to a considerably
greater extent in females. Thus, we hypothesize that part
of the observed alterations in gene expression patterns in
female offspring may indicate molecular mechanismsFigure 5 Schematic overview of signaling cascades affected by pr
frontal cortex (B). Genes upregulated by prenatal stress are highligh
stress are shown in red (or dark grey). Arrows represent positive in
more information, see text. Abbreviations: 5-HT/NE: Serotonin (5-HT
monophosphate; APC: Adenomatous polyposis coli; ATP: Adenosine t
B-catenin binding protein; Ca2+: Calcium 2+; CaM: Calmoduline; Ca
AMP; CaN: Calcineurin; CBP: CREB-binding protein; CREB: cAM
DSH: Disheveled; DUSP: dual speciﬁcity phosphatase; EGF: Epiderm
Gs: Guanine-nucleotide binding protein, stimulatory; GSK3B: Glyco
Inositol monophosphatase; IP3: Inositol 1,4,5-triphosphate; MAPK: M
receptor-related protein 6; MBD1: methyl-CpG-binding domain pro
P: Phosphate/phospho-; p53: Protein 53; PDEs: Phosphodiesterases
nositol 3-kinase; PIP2: Phosphatidylinositol (4,5)-bisphosphate; PIP3
A; PKC: Protein kinase C; PLC: Phospholipase-C; R: Receptor; Raf
RSK: Ribosomal protein S6 kinase; TCF/LEF: T-cell factor/lymphoid
references to color in this ﬁgure legend, the reader is referred toinducing resilience to PS. As such, microarray analysis
within the hippocampus and FC highlighted various signaling
pathways which may be critically involved in the develop-
ment of mood disorders and/or the actions of antidepres-
sants. Examples include glutamatergic and GABAergic
signaling, the cAMP/cGMP/PDE system, the MAPK pathway,
insulin signaling, and the GSK-3 signaling pathway.
Altogether, the current study suggests that resilience to
developmental stress exposure may be mediated, at least in
part, via these intracellular signaling cascades. Further-
more, these signaling pathways may provide potential
targets for novel antidepressant and mood stabilizing
drug treatments, including e.g. HDAC inhibitors and PDE
inhibitors.
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